UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42164 SIM Acquisition Corp. I (Exact name of registrant as specified in its charter) | Cayman Islands | 35-2838851 | | --- | --- | | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2025 VolitionRx Limited (Exact name of registrant as specified in its charter) Delaware 001-36833 91-1949078 (State or other jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification Number) Check the appropriate box below if the Form 8-K filing is intended ...

Earnings Release - ICF International, Inc. will release its Q4 and full year 2024 earnings results on February 27, 2025, after market close[6] - A conference call to discuss the results will be held at 4:30 p.m. Eastern Time on the same day[6]

Financial Performance - Sales increased by 38% to $38.1 million in 2024, compared to $27.6 million in the prior year, driven by production growth from facilities in Georgia, Texas, and Washington[5] - Gross profit for 2024 was $4.1 million, with an adjusted gross margin of approximately 27%, consistent with the prior year, reflecting production ramp-up at new facilities[5] - Operating loss improved by $57.9 million to $59.0 million in 2024, compared to a loss of $116.9 million in 2023, which included a non-cash goodwill impairment charge[9] - Net loss for 2024 was $119.9 million, slightly improved from a net loss of $124.0 million in the prior year[9] - Sales for Q4 2024 reached $10,070,000, a 46% increase from $6,866,000 in Q4 2023[34] - The net loss for Q4 2024 was $36,258,000, an improvement from a net loss of $65,554,000 in Q4 2023[34] - The company reported a basic and diluted net loss per share of $4.21 for Q4 2024, compared to $8.10 for Q4 2023[34] Expenses and Costs - Research and development expenses increased to $22.3 million in 2024, with expectations for future decreases as production thresholds for new product lines are reached[9] - Total operating expenses for Q4 2024 were $17,314,000, down from $59,932,000 in Q4 2023, primarily due to a reduction in goodwill impairment[34] - Research and development expenses for Q4 2024 were $7,185,000, significantly higher than $3,983,000 in Q4 2023[34] - Selling, general and administrative expenses for Q4 2024 were $10,129 thousand, down from $17,468 thousand in Q4 2023, representing a decrease of 42.4%[36] - Adjusted selling, general and administrative expenses for the twelve months ended December 31, 2024, were $28,185 thousand, down from $30,200 thousand in 2023, a decrease of 6.7%[36] - Stock-based compensation expense for Q4 2024 was $1,247 thousand, down from $2,616 thousand in Q4 2023, a reduction of 52.3%[37] - Interest expense, net for the twelve months ended December 31, 2024, increased to $58,923 thousand from $25,745 thousand in 2023, an increase of 128.5%[37] - Depreciation and amortization for the twelve months ended December 31, 2024, was $18,871 thousand, up from $13,132 thousand in 2023, an increase of 43.7%[37] - Business acquisition and strategic transaction costs for the twelve months ended December 31, 2024, were $2,479 thousand, down from $6,902 thousand in 2023, a decrease of 64.0%[37] - Loss on disposal of fixed assets for the twelve months ended December 31, 2024, was $1,651 thousand, compared to $4,709 thousand in 2023, a decrease of 64.9%[37] Funding and Capital Structure - The company secured $27.5 million in new funding, including $25 million in equity and $2.5 million in capex financing, while restructuring $197 million in debt with a nearly 40% reduction[2][4] - Total assets increased to $428,035,000 as of December 31, 2024, up from $381,752,000 in 2023[32] - Current liabilities rose to $55,436,000 in Q4 2024, compared to $31,941,000 in Q4 2023[32] - Long-term debt increased to $416,577,000 in Q4 2024, up from $277,985,000 in Q4 2023[32] Future Outlook - The company expects first quarter 2025 sales of approximately $11.5 million, reflecting ongoing product mix transitions at its Texas facility[21] - Local Bounti aims to achieve positive adjusted EBITDA by the third quarter of 2025, supported by improved capital structure and operational efficiencies[22] Leadership Changes - Leadership transition occurred with Kathleen Valiasek appointed as CEO, succeeding Craig Hurlbert, who became Executive Chairman[18] Gross Profit and Margins - Adjusted gross profit for Q4 2024 was $2,478,000, with an adjusted gross margin percentage of 25%[35] - Gross profit for Q4 2024 was $540,000, compared to $680,000 in Q4 2023, reflecting a decrease in gross margin percentage[34] - Adjusted EBITDA for the twelve months ended December 31, 2024, was $(32,084) thousand, slightly improved from $(34,082) thousand in 2023[37] Goodwill Impairment - Goodwill impairment recorded in Q4 2023 was $38,481 thousand, with no impairment reported in Q4 2024[37]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission file number 001-41346 NUTEX HEALTH INC. (State or other jurisdiction of incorporation or organization) (I.R.S. Employer ...

Technology and Innovation - ClearSign Core™ technology can reduce nitrogen oxide (NOx) emissions to levels of 5 parts per million (ppm) or below, enhancing compliance with stringent emission regulations[32] - Burners utilizing ClearSign Core™ technology can achieve increased heat transfer efficiency, potentially resulting in cost savings in the low to mid-single digit percentage range[18] - ClearSign Core™ technology is designed to operate without the need for external flue gas recirculation or selective catalytic reduction systems, making it more cost-effective than traditional air pollution control technologies[17] - ClearSign Core™ technology has demonstrated the ability to burn fuels with up to 80% hydrogen while controlling NOx emissions, positioning the company for future hydrogen fuel applications[30] - The company is developing the ClearSign Eye flame sensing technology, which can be retrofitted into existing burner systems and is applicable to various markets beyond emissions reduction[19] - ClearSign's technology aims to minimize maintenance and downtime, enhancing overall operational efficiency for industrial applications[18] - ClearSign's technology focuses on core components that enhance combustion performance while minimizing emissions, positioning the company favorably against upcoming environmental regulations[69] - ClearSign's research and development efforts are focused on optimizing technology for customer adoption and expanding into adjacent market verticals, including flame sensing and hydrogen burner technology[87] Market and Customer Engagement - The company has successfully deployed its combustion technology in commercial projects, including downstream refining and upstream oil production[16] - The company has targeted the energy sector, including downstream oil refineries and upstream crude oil production, as initial markets for its technology[24] - Recent regulatory changes in California have led to significant reductions in target NOx emissions, increasing demand for ClearSign's products[26] - The company has one installation operating in a major global oil refiner in Europe, indicating international market expansion[29] - ClearSign CoreTM technology has been deployed in six process heaters for global supermajor and Fortune 500 companies, with installations in California and Europe[44] - In 2022, ClearSign received a purchase order for twenty process burners from a California refinery, with installation now expected in Q3 2025 due to project delays[45] - The company has received three additional orders for modified ClearSign CoreTM boiler burners, indicating a growing market opportunity in low emissions burners[46] - ClearSign's operational strategy emphasizes partnerships with major OEM manufacturers to enhance product offerings and reduce market entry barriers, aiming for significant commercial opportunities[70] - In 2024, ClearSign's sales strategy targeting OEM heater companies resulted in multiple orders from a single heater OEM, indicating effective market penetration[74] Financial Performance - Revenues for the year ended December 31, 2024, increased by $1,193 thousand, or 49.6%, to $3,596 thousand compared to $2,403 thousand in 2023[206] - Gross profit rose by $301 thousand, or 36.8%, for the year ended December 31, 2024, resulting in a gross profit margin decrease from 34.0% in 2023 to 31.1% in 2024[207] - The net loss for the year ended December 31, 2024, was $5,299 thousand, a slight increase of $105 thousand compared to a net loss of $5,194 thousand in 2023[205] - The company reported that its two California refinery customers accounted for 86% and 87% of annual revenue for the years ended December 31, 2024, and 2023, respectively[80] - The company has incurred total losses of $99.0 million since inception and expects to continue experiencing operating losses and negative cash flow for the foreseeable future[182] Research and Development - The company has received approximately $1.9 million in grants from the Department of Energy to develop a hydrogen-capable burner, with a target completion date in 2025[49] - Research and development expenses surged by $732 thousand, or 99.1%, for the year ended December 31, 2024, primarily due to increased headcount and product development costs[209] - The increase in R&D expenses included $269 thousand for additional headcount and $367 thousand for product development costs in 2024[209] - The company is currently engaged in R&D for a 100% hydrogen-capable burner aimed at reducing industrial emissions of CO2 and NOx[48] Risks and Challenges - The company faces risks associated with market acceptance of its technology, which is difficult to predict and may impede revenue generation[101] - The company is subject to sustainability efforts risks that could adversely affect its reputation and business due to changing views on environmental issues[107] - The company operates in a highly competitive combustion industry, where many competitors have greater resources and capabilities[120] - The company is exposed to significant risks related to its business activities in China, including economic, political, and legal uncertainties that could adversely affect operations[123] - The company cannot assure that rising inflation will not negatively impact its operations, although the impact has been moderate in recent years[126] - Global supply-chain constraints have had a moderate impact on the company, but future disruptions could adversely affect commercialization efforts and operating results[131] - The company is dependent on third-party suppliers for raw materials, and any failure or delays from these suppliers could materially affect operations[134] - The company may require substantial additional funds in excess of current financial resources for research, development, and commercialization of its technology[100] Corporate Governance and Structure - The company has established a collaborative agreement with Zeeco, a leading burner manufacturer, to globally produce ClearSign CoreTM process burners, with a co-branded product line expected to launch in December 2024[71] - The company operates under an "asset light" model, utilizing subcontractors for sourcing and manufacturing, which minimizes capital investment and maximizes resource efficiency[82] - The company aims to utilize an "asset light" model by collaborating with strategic partners to maximize profitability and service capabilities[68] - The company has no committed source of financing and cannot assure that it will be able to raise funds as needed to continue operations[187] Shareholder Information - The company has not paid any cash dividends to date and does not anticipate doing so in the foreseeable future[177] - The company may need to raise additional capital, which could dilute existing shareholders and adversely affect the market price of its common stock[144] - The company has increased the number of authorized shares of common stock from 62.5 million to 87.5 million[194] - As of December 31, 2024, the company had outstanding options for the purchase of 2,943 thousand shares of common stock and 864 thousand shares of restricted stock units (RSUs)[149] Cybersecurity - The company has engaged third-party cybersecurity consultants to assess its cybersecurity practices using the NIST Cybersecurity Framework[166] - The company recognizes the importance of robust cybersecurity measures and has implemented continuous improvement processes for risk management[163]

Revenue and Financial Performance - In 2024, the Company reported total revenue of $25.4 million, with over 80% derived from recurring sources such as cloud-based hosting and disaster recovery solutions[36]. - Revenue for the year ended December 31, 2024, increased by approximately 2% to $25,371,303 compared to $24,959,576 for the year ended December 31, 2023[166]. - The Company derived approximately 51% of revenue from infrastructure & disaster recovery/cloud services, 31% from equipment and software sales, 12% from managed services, and 5% from Nexxis VoIP services for the year ended December 31, 2024[166]. - The Company reported net income attributable to common shareholders of $523,214 for the year ended December 31, 2024, compared to $381,575 for 2023, indicating a year-over-year increase of approximately 37%[52]. - Adjusted EBITDA for the year ended December 31, 2024, was $2,365,238, compared to $1,639,388 for 2023, reflecting an increase in operational performance[191]. - Cash provided by operating activities for the year ended December 31, 2024, was $1,740,089, a decrease from $3,873,047 in 2023, primarily due to an increase in accounts receivable of $1,010,880[185]. - The company's working capital increased to $11,869,914 on December 31, 2024, up by $858,507 from $11,011,407 at the end of 2023[182]. Customer Base and Retention - The Company has a contract renewal rate exceeding 90%, positioning it to maintain and expand its customer base[36]. - The Company ended the year with a $21.5 million Annual Recurring Revenue (ARR) run rate[36]. - The Company has historically maintained over 90% annual subscription renewal rates, reflecting strong customer retention[164]. - For the year ended December 31, 2024, two customers each accounted for 12% of the Company's revenue, while in 2023, two customers accounted for 12% and 10% respectively, highlighting dependency on a limited customer base[69]. - The Company’s client base exceeds 425 organizations across diverse sectors, indicating broad market demand for its services[164]. Operational and Strategic Developments - The integration of Flagship Solutions into CloudFirst was completed in January 2024, enhancing operational synergies and cross-selling opportunities[23]. - The Company is focused on expanding its cloud footprint and cross-selling its full suite of solutions to meet evolving client needs[34]. - The Company plans to continue acquiring complementary solutions and services, which may divert management's attention and increase operating costs[58]. - The Company anticipates ongoing international expansion, which will require substantial investment in marketing and localized services[106]. Risks and Challenges - The competitive landscape for cloud solutions is intense, with significant competition from established players like IBM, Microsoft, Google, and AWS, which may impact the Company's market position[70]. - The Company is exposed to risks related to cybersecurity, as breaches could disrupt its data protection services and harm its reputation[76]. - The Company faces challenges in retaining existing customers, and a significant decrease in retention rates could necessitate higher marketing expenses to maintain revenue[89]. - The Company must maintain effective advertising and marketing strategies to attract new customers, as failure to do so could lead to increased expenses and reduced operating results[55]. - The Company is subject to evolving privacy regulations, and any failure to comply could result in legal actions and loss of customer trust[97]. - The Company faces risks associated with international operations, including economic and political instability, currency fluctuations, and differing legal environments[107]. - The Company is exposed to risks from fluctuations in foreign currency exchange rates, which could adversely affect reported earnings[109]. Financial Position and Capital Management - As of December 31, 2024, the Company had cash of $1,070,097 and marketable securities totaling $11,261,006, with working capital amounting to $11,869,914[52]. - The Company does not expect to declare any cash dividends in the foreseeable future, meaning shareholders may need to rely on share price appreciation for returns[138]. - The Company may face challenges in raising additional capital due to market conditions and the potential dilution from outstanding securities[136]. - The Company has received a Notification Letter from Nasdaq confirming compliance with audit committee requirements, thus maintaining its listing on The Nasdaq Capital Market[134]. Compliance and Regulatory Matters - The Company must comply with HIPAA and HITECH regulations, which include privacy standards that protect individual health information[99]. - The Company may face penalties for non-compliance with federal and state standards regarding patient privacy, which could adversely affect its business[100]. - The Company maintains a cyber risk management program that includes annual risk assessments to identify and mitigate cybersecurity threats[142]. Market and Economic Conditions - The Company's revenue is heavily concentrated in the U.S., making it vulnerable to fluctuations in demand within this market[91]. - The Company's operations could be negatively impacted by changes in trade policies and economic conditions, affecting its financial results[119].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-42374 SYNERGY CHC CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organ ...

Revenue Performance - Total revenue for the three months ended February 28, 2025, was $238.0 million, representing a 29% increase compared to $184.7 million for the same period in 2024[71] - ShareFile contributed $63.6 million to revenue in the first quarter of fiscal year 2025 following its acquisition[71] - Software license revenue decreased by 9% to $58.4 million, down from $64.1 million, accounting for 25% of total revenue[72] - Maintenance, SaaS, and professional services revenue increased by 49% to $179.6 million, representing 75% of total revenue[73] - North America generated $154.6 million in revenue, a 44% increase from $107.3 million, accounting for 65% of total revenue[74] Profitability and Expenses - Gross profit increased by 26% to $191.8 million, with a gross margin of 81%[79] - Sales and marketing expenses rose by 31% to $51.3 million, representing 22% of total revenue[80] - Product development costs increased by 33% to $46.4 million, maintaining 19% of total revenue[81] - General and administrative expenses increased by 20% to $25.6 million, accounting for 11% of total revenue[82] - Amortization of intangibles increased by 48% to $25.8 million, representing 11% of total revenue due to the acquisition of ShareFile[83] - Cyber vulnerability response expenses decreased by 25% year-over-year, totaling $737,000 for the three months ended February 28, 2025, compared to $987,000 for the same period in 2024[84] - Restructuring expenses increased by 199%, amounting to $7,029,000 for the three months ended February 28, 2025, up from $2,349,000 in the prior year[86] - Acquisition-related expenses rose by 255%, reaching $2,490,000 for the three months ended February 28, 2025, compared to $702,000 in the same period of 2024[87] Income and Cash Flow - Income from operations decreased by 7%, totaling $32,426,000 for the three months ended February 28, 2025, down from $35,006,000 in the prior year[88] - Net income fell by 52%, amounting to $10,946,000 for the three months ended February 28, 2025, compared to $22,639,000 for the same period in 2024[91] - Net cash flows from operating activities were $68,947,000 for the three months ended February 28, 2025, compared to $70,504,000 in the same period of 2024[104] - Cash and cash equivalents increased by $6.1 million from the end of fiscal year 2024, totaling $124,161,000 as of February 28, 2025[102] Recurring Revenue and Customer Retention - Annualized Recurring Revenue (ARR) increased by 48% year-over-year, reaching $836 million as of February 28, 2025, up from $566 million in the prior year[99] - Net retention rates remained stable, generally ranging between 100% and 102% for all periods presented, indicating strong customer retention[101] Strategic Decisions and Risks - The company suspended its quarterly dividend to redirect capital towards debt repayment and future M&A activities following the ShareFile acquisition[110] - MOVEit Transfer products were attacked, leading to compromised personal data and ongoing class action lawsuits[114] - The litigation related to the MOVEit Vulnerability is in an early stage, with motions to dismiss filed but not yet ruled upon[114] - Future expenses and liabilities from the MOVEit Vulnerability are expected to be mitigated by insurance[115] - No significant changes to market risk disclosures were noted during the first three months of fiscal year 2025[117]

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights Exhibit 99.1 Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled Recent Corporate Highlights1: Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; Checkpoint's lead product, UNLOXCYT™, approved by FDA for the treatment of metastatic or locally advanced cutaneous squamous cell carc ...